Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Quinine topical nasal spray - GeneOne Life Science

X
Drug Profile

Quinine topical nasal spray - GeneOne Life Science

Alternative Names: GLS-1200

Latest Information Update: 12 Oct 2022

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator GeneOne Life Science
  • Class Antimalarials; Antiprotozoals; Cinchona alkaloids; Muscle relaxants; Non-opioid analgesics; Quinolines; Quinuclidines; Small molecules
  • Mechanism of Action G protein-coupled receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II COVID 2019 infections; Rhinosinusitis

Most Recent Events

  • 12 Oct 2022 Phase-II clinical trials in Rhinosinusitis (Prevention) in USA (Intranasal) (GeneOne Life Science pipeline, October 2022)
  • 07 Oct 2022 Quinine topical nasal spray is still in phase II trials for COVID-2019 infections in USA (NCT04408183) (GeneOne Life Science pipeline, October 2022)
  • 29 Sep 2022 GeneOne Life Science terminates a phase II trial in COVID-2019 infections (Prevention) in USA (Intranasal) due to no longer enrolling (NCT04408183)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top